Molecular basis of prion diseases

Journal of NeuroVirology

Volumn 8, Issue SUPPL. 2, 2002, Pages 8-20

  Riesner, Detlev ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Diagnosis; Epidemilogy; Pathology; Prions; Replication; Structure

Indexed keywords

ACTIN; AMYLOID; BIOLOGICAL MARKER; GAMMA INTERFERON; GLUCOSE POLYMER; LAMININ RECEPTOR; LIPID; PRION PROTEIN; PROTEIN KINASE; RNA;

AMINO ACID SUBSTITUTION; BETA SHEET; BOVINE SPONGIFORM ENCEPHALOPATHY; CATALYSIS; CELL NUCLEUS; CELL SURFACE; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONFORMATIONAL TRANSITION; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; ENZYME MECHANISM; GENE AMPLIFICATION; GENETIC TRANSFORMATION; HUMAN; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; REVIEW; SENSITIVITY AND SPECIFICITY; SOLUBILITY; STRUCTURE ANALYSIS; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS RESISTANCE;

BOVINAE;

EID: 0036948071     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280290101120     Document Type: Review

References (42)

1. Alper T, Haig DA, Clarke MC (1966). The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun 22: 278-284.
2. Appel TR, Dumpitak C, Matthiesen U, Riesner D (1999). Prion rods contain an inert polysaccharide scaffold. Biol Chem 380: 1296-1306.
3. Bieschke J, Giese A, Schulz-Schaeffer W, Zerr I, Poser S, Eigen M, Kretzschmar H (2000). Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc Natl Acad Sci USA 97: 5468-5473.
4. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, von Bohlen A, Schulz-Schaeffer W, Giese A, Westaway D, Kretzschmar H (1997). The cellular prion protein binds copper in vivo. Nature 390: 684-687.
5. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993). Mice devoid of PrP are resistant to scrapie. Cell 73: 1339-1347.
6. Cohen FE, Prusiner SB (1998). Pathologic conformations of prion proteins. Annu Rev Biochem 67: 793-819.
7. Collinge SB, Collinge J, Jefferys JG (1996). Hippocampal slices from prion protein null mice: disrupted Ca(2+)-activated K+ currents. Neurosci Lett 209: 49-52.
8. Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, Jefferys JG (1994). Prion protein is necessary for normal synaptic function. Nature 370: 295-297.
9. Come JH, Fraser PE, Lansbury PT Jr (1993). A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci USA 90: 5959-5963.
10. Creutzfeldt HG (1920). Über eine eigenartige herdförmige Erkrankung des Zentralnervensystems. Z Gesamte Neurol Psychiatrie 57: 1-18.
11. Cuillé (1938). La tremblante du mounton est bien inoculable. Acad Sci Paris 206: 78-79.
12. Eigen M (2001). BSE und das Prionen Problem. Spektrum der Wissenschaften April:
13. Fraser H, Dickinson AG (1968). The sequential development of the brain lesion of scrapie in three strains of mice. J Comp Pathol 78: 301-311.
14. Gajdusek DC (1977). Unconventional viruses and the origin and disappearance of kuru. Science 197: 943-960.
15. Gauczynski S, Peyrin JM, Haik S, Leucht C, Hundt C, Rieger R, Krasemann S, Deslys JP, Dormont D, Lasmezas CI, Weiss S (2001). The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 20: 5863-5875.
16. Hadlow WJ (1959). Scrapie and kuru. Lancet ii: 289-290.
17. Jakob A (1921). Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswerten anatomischen Befunden (spastische Pseudosklerose-Encephalomyelopathie) mit disseminierten Degenerationsherden). Z Gesamte Neurol Psychiatrie 64: 147-228.
18. Jansen K, Schafer O, Birkmann E, Post K, Serban H, Prusiner SB, Riesner D (2001). Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form. Biol Chem 382: 683-691.
19. Klein TR, Kirsch D, Kaufmann R, Riesner D (1998). Prion rods contain small amounts of two host sphingolipids as revealed by thin-layer chromatography and mass spectrometry. Biol Chem 379: 655-666.
20. Korth C, May BC, Cohen FE, Prusiner SB (2001). Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci USA 98: 9836-9841.
21. Kretzschmar HA (1993). Neuropathology of human prion diseases (spongiform encephalopathies). Dev Biol Stand 80: 71-90.
22. Leopoldt JG (1759). Nützliche und auf die Erfahrung gegründete Einleitung zur Landwirtschaft 5: 344-360.
23. Meyer N, Rosenbaum V, Schmidt B, Gilles K, Mirenda C, Groth D, Prusiner SB, Riesner D (1991). Search for a putative scrapie genome in purified prion fractions reveals a paucity of nucleic acids. J Gen Virol 72(Pt 1): 37-49.
24. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O (2000). Signal transduction through prion protein. Science 289: 1925-1928.
25. Oesch B, Westaway D, Walchli M, McKinley MP, Kent SB, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE (1985). A cellular gene encodes scrapie PrP 27-30 protein. Cell 40: 735-746.
26. Pitschke M, Prior R, Haupt M, Riesner D (1998). Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy. Nat Med 4: 832-834.
27. Post K, Pitschke M, Schafer O, Wille H, Appel TR, Kirsch D, Mehlhorn I, Serban H, Prusiner SB, Riesner D (1998). Rapid acquisition of beta-sheet structure in the prion protein prior to multimer formation. Biol Chem 379: 1307-1317.
28. Prusiner SB (1982). Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144.
29. Prusiner SB (1993). Genetic and infectious prion diseases. Arch Neurol 50: 1129-1153.
30. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, Wuthrich K (1996). NMR structure of the mouse prion protein domain PrP(121-321). Nature 382: 180-182.
31. Riesner D (1992). The search for a nucleic acid component to scrapie infectivity. SemiVirol 2: 215-226.
32. C. In: Prionen and Prionkrankheiten, Hörnliman B, Riesner D (eds). De Gruyter: Berlin, pp 81-91.
33. Riesner D, Kellings K, Post K, Wille H, Serban H, Groth D, Baldwin MA, Prusiner SB (1996). Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity. J Virol 70: 1714-1722.
34. Saborio GP, Permanne B, Soto C (2001). Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411: 810-813.
35. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB (1998). Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 4: 1157-1165.
36. Sakaguchi S, Katamine S, Nishida N, Moriuchi R, Shigematsu K, Sugimoto T, Nakatani A, Kataoka Y, Houtani T, Shirabe S, Okada H, Hasegawa S, Miyamoto T, Noda T (1996). Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380: 528-531.
37. Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, Crossin KL, Edelman GM, DeArmond SJ, Cohen FE, Prusiner SB (2001). Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 314: 1209-1225.
38. Scott MR, Supattapone S, Nguyen HO, DeArmond SJ, Prusiner SB (2000). Transgenic models of prion disease. Arch Virol Suppl 113-124.
39. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, DeArmond SJ, Prusiner SB (1995). Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83: 79-90.
40. Tobler I, Gaus SE, Deboer T, Achermann P, Fischer M, Rulicke T, Moser M, Oesch B, McBride PA, Manson JC (1996). Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380: 639-642.
41. Wells GA, Scott AC, Johnson CT, Gunning RF, Hancock RD, Jeffrey M, Dawson M, Bradley R (1987). A novel progressive spongiform encephalopathy in cattle. Vet Rec 121: 419-420.
42. Zigas V (1990). Laughing death-the untold story of kuru. Human Press: Clifton, NJ.